Cargando…

Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE)

BACKGROUND: Factors related to early stimulation of the immune system (breastfeeding, proxies for exposure to infectious agents, normal delivery, and exposure to animals in early life) have been suggested to decrease the risk of childhood acute lymphoblastic leukaemia (ALL). METHODS: The national re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajrouche, R, Rudant, J, Orsi, L, Petit, A, Baruchel, A, Lambilliotte, A, Gambart, M, Michel, G, Bertrand, Y, Ducassou, S, Gandemer, V, Paillard, C, Saumet, L, Blin, N, Hémon, D, Clavel, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366894/ https://www.ncbi.nlm.nih.gov/pubmed/25675150 http://dx.doi.org/10.1038/bjc.2015.53

Ejemplares similares

Household Exposure to Pesticides and Risk of Childhood Hematopoietic Malignancies: The ESCALE Study (SFCE)
por: Rudant, Jérémie, et al.
Publicado: (2007)

ARID5B, IKZF1 and Non-Genetic Factors in the Etiology of Childhood Acute Lymphoblastic Leukemia: The ESCALE Study
por: Rudant, Jérémie, et al.
Publicado: (2015)

Road Traffic and Childhood Leukemia: The ESCALE Study (SFCE)
por: Amigou, Alicia, et al.
Publicado: (2011)

COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
por: Baruchel, André, et al.
Publicado: (2020)

COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
por: Rouger-Gaudichon, Jérémie, et al.
Publicado: (2021)

Spatial and space–time clustering of childhood acute leukaemia in France from 1990 to 2000: a nationwide study
por: Bellec, S, et al.
Publicado: (2006)

Childhood leukaemia and population movements in France, 1990–2003
por: Bellec, S, et al.
Publicado: (2008)

The 2022 Lady Estelle Wolfson lectureship on neurofilaments
por: Petzold, Axel
Publicado: (2022)

Childhood leukaemia close to high-voltage power lines – the Geocap study, 2002–2007
por: Sermage-Faure, C, et al.
Publicado: (2013)

Improving the efficiency of automated protocol implementation using Estelle
por: Gotzhein, R, et al.
Publicado: (1995)

French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
por: Trioche, Pascale, et al.
Publicado: (2012)

The formal description technique Estelle: results of the ESPRIT/SEDOS project
por: Díaz, Michel
Publicado: (1989)

Reply: Comment on ‘Childhood leukaemia close to high-voltage power lines – the Geocap study, 2002–2007' – Is proximity an appropriate MF exposure surrogate?
por: Clavel, J, et al.
Publicado: (2013)

Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE)
por: de Tersant, Marie, et al.
Publicado: (2020)

Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
por: van der Sluis, Inge M., et al.
Publicado: (2022)

Day-care, early common infections and childhood acute leukaemia: a multicentre French case–control study
por: Perrillat, F, et al.
Publicado: (2002)

Residential proximity to croplands at birth and childhood leukaemia
por: Bamouni, Sophie, et al.
Publicado: (2022)

Reply: Comment on ‘Childhood leukaemia close to high-voltage power lines – the Geocap study, 2002–2007' – Odds ratio and confidence interval
por: Clavel, J, et al.
Publicado: (2013)

Incidence of childhood leukaemia in the vicinity of nuclear sites in France, 1990–1998
por: White-Koning, M L, et al.
Publicado: (2004)

High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group
por: Marec-Berard, Perrine, et al.
Publicado: (2014)

A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology
por: Hungate, Eric A., et al.
Publicado: (2016)

Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol
por: Winnicki, Camille, et al.
Publicado: (2023)

SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers
por: Jannier, Sarah, et al.
Publicado: (2020)

Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia
por: Jourdan-Da Silva, N, et al.
Publicado: (2004)

Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group
por: Blais, S., et al.
Publicado: (2019)

Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study
por: Tabone, Marie-Dominique, et al.
Publicado: (2021)

Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion
por: Baruchel, André, et al.
Publicado: (2020)

Childhood leukaemia incidence around French nuclear installations using geographic zoning based on gaseous discharge dose estimates
por: Evrard, A-S, et al.
Publicado: (2006)

Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia
por: Kwan, M L, et al.
Publicado: (2005)

Seasonality in the diagnosis of childhood acute lymphoblastic leukaemia.
por: Thorne, R., et al.
Publicado: (1998)

Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)
por: Donadieu, J, et al.
Publicado: (2000)

Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial
por: Petit, Arnaud, et al.
Publicado: (2018)

Daycare attendance and risk of childhood acute lymphoblastic leukaemia
por: Ma, X, et al.
Publicado: (2002)

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
por: Lilleyman, J. S., et al.
Publicado: (1984)

Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia
por: Pal, D, et al.
Publicado: (2016)

T lymphoblastic leukaemia and the central nervous system.
por: Lilleyman, J. S., et al.
Publicado: (1981)

Long survival in childhood lymphoblastic leukaemia.
por: Chessells, J. M., et al.
Publicado: (1987)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_scu0jmbvfnggkdto30pgueeum0